Anpario Plc Net Assets
Anpario Plc net assets. Based on the latest financial reports, Anpario Plc (ANP) has net assets worth GBX40.96 Million GBX (≈ $4.98K USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX50.49 Million ≈ $6.14K USD) and total liabilities (GBX9.53 Million ≈ $1.16K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore ANP net assets growth trend to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX40.96 Million |
| % of Total Assets | 81.13% |
| Annual Growth Rate | N/A |
| 5-Year Change | 1.64% |
| 10-Year Change | 43.54% |
| Growth Volatility | 72.05 |
Net Assets of Anpario Plc (2000–2025)
Net assets of Anpario Plc from 2000 to 2025. This chart illustrates how Anpario Plc's net assets have evolved over time, based on quarterly financial data. See how leveraged is Anpario Plc's balance sheet to measure how much of total assets are equity-financed.
Annual Net Assets for Anpario Plc (2000–2025)
The table below shows the annual net assets of Anpario Plc from 2000 to 2025. For live market cap and overall valuation, see ANP company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | GBX40.96 Million ≈ $4.98K |
+12.86% |
| 2024-12-31 | GBX36.29 Million ≈ $4.42K |
+7.86% |
| 2023-12-31 | GBX33.65 Million ≈ $4.09K |
-18.55% |
| 2022-12-31 | GBX41.31 Million ≈ $5.03K |
+2.50% |
| 2021-12-31 | GBX40.30 Million ≈ $4.90K |
+7.46% |
| 2020-12-31 | GBX37.51 Million ≈ $4.56K |
+5.49% |
| 2019-12-31 | GBX35.55 Million ≈ $4.33K |
+7.26% |
| 2018-12-31 | GBX33.15 Million ≈ $4.03K |
+8.60% |
| 2017-12-31 | GBX30.52 Million ≈ $3.71K |
+6.96% |
| 2016-12-31 | GBX28.54 Million ≈ $3.47K |
+7.35% |
| 2015-12-31 | GBX26.58 Million ≈ $3.23K |
+16.87% |
| 2014-12-31 | GBX22.75 Million ≈ $2.77K |
+13.00% |
| 2013-12-31 | GBX20.13 Million ≈ $2.45K |
+12.55% |
| 2012-12-31 | GBX17.89 Million ≈ $2.18K |
+11.77% |
| 2011-12-31 | GBX16.00 Million ≈ $1.95K |
+8.21% |
| 2010-12-31 | GBX14.79 Million ≈ $1.80K |
+8.70% |
| 2009-12-31 | GBX13.61 Million ≈ $1.66K |
+80.53% |
| 2008-12-31 | GBX7.54 Million ≈ $916.91 |
+5.72% |
| 2007-12-31 | GBX7.13 Million ≈ $867.27 |
+5.41% |
| 2006-12-31 | GBX6.76 Million ≈ $822.74 |
+263.16% |
| 2005-12-31 | GBX1.86 Million ≈ $226.55 |
+200.81% |
| 2004-12-31 | GBX619.00K ≈ $75.31 |
+1114.75% |
| 2003-12-31 | GBX-61.00K ≈ $-7.42 |
-306.67% |
| 2002-12-31 | GBX-15.00K ≈ $-1.83 |
-105.05% |
| 2001-12-31 | GBX297.00K ≈ $36.14 |
+257.14% |
| 2000-12-31 | GBX-189.00K ≈ $-23.00 |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Anpario Plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2875000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Anpario Plc Net Assets Breakdown (December 2025)
Anpario Plc net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | GBX28.75 Million | 70.19% |
| Common Stock | GBX4.74 Million | 11.58% |
| Other Comprehensive Income | GBX3.39 Million | 8.27% |
| Other Components | GBX4.08 Million | 9.97% |
| Total Equity | GBX40.96 Million | 100.00% |
Anpario Plc Competitors by Market Cap
The table below lists competitors of Anpario Plc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Alligator Bioscience AB
ST:ATORX
|
$1.00 Million |
|
Antarctica Limited
NSE:ANTGRAPHIC
|
$1.01 Million |
|
BioNeutra Global Corp
V:BGA
|
$1.01 Million |
|
PHAXIAM Therapeutics S.A.
PA:PHXM
|
$1.01 Million |
|
Quintegra Solutions Limited
NSE:QUINTEGRA
|
$1.00 Million |
|
Fram Skandinavien AB Series B
ST:FRAM-B
|
$1.00 Million |
|
Sarawak Cable Bhd
KLSE:5170
|
$1.00 Million |
|
4BASEBIO UK SOCIETAS
LSE:4BB
|
$998.55K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Anpario Plc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 36,294,000 to 40,963,000, a change of 4,669,000 (12.9%).
- Net income of 6,752,000 contributed positively to equity growth.
- Dividend payments of 2,056,000 reduced retained earnings.
- Share repurchases of 693,000 reduced equity.
- New share issuances of 601,000 increased equity.
- Other comprehensive income increased equity by 64,999.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX6.75 Million | +16.48% |
| Dividends Paid | GBX2.06 Million | -5.02% |
| Share Repurchases | GBX693.00K | -1.69% |
| Share Issuances | GBX601.00K | +1.47% |
| Other Comprehensive Income | GBX65.00K | +0.16% |
| Other Changes | GBX1.00 | +0.0% |
| Total Change | GBX- | 12.86% |
Book Value vs Market Value Analysis
This analysis compares Anpario Plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 220.72x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | GBX-0.01 | GBX508.00 | x |
| 2003-12-31 | GBX-0.02 | GBX508.00 | x |
| 2004-12-31 | GBX0.24 | GBX508.00 | x |
| 2005-12-31 | GBX0.85 | GBX508.00 | x |
| 2006-12-31 | GBX1.73 | GBX508.00 | x |
| 2007-12-31 | GBX0.65 | GBX508.00 | x |
| 2008-12-31 | GBX0.68 | GBX508.00 | x |
| 2009-12-31 | GBX0.92 | GBX508.00 | x |
| 2010-12-31 | GBX0.80 | GBX508.00 | x |
| 2011-12-31 | GBX0.88 | GBX508.00 | x |
| 2012-12-31 | GBX0.94 | GBX508.00 | x |
| 2013-12-31 | GBX1.03 | GBX508.00 | x |
| 2014-12-31 | GBX1.13 | GBX508.00 | x |
| 2015-12-31 | GBX1.31 | GBX508.00 | x |
| 2016-12-31 | GBX1.39 | GBX508.00 | x |
| 2017-12-31 | GBX1.45 | GBX508.00 | x |
| 2018-12-31 | GBX1.53 | GBX508.00 | x |
| 2019-12-31 | GBX1.69 | GBX508.00 | x |
| 2020-12-31 | GBX1.77 | GBX508.00 | x |
| 2021-12-31 | GBX1.82 | GBX508.00 | x |
| 2022-12-31 | GBX1.89 | GBX508.00 | x |
| 2023-12-31 | GBX1.79 | GBX508.00 | x |
| 2024-12-31 | GBX2.16 | GBX508.00 | x |
| 2025-12-31 | GBX2.30 | GBX508.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Anpario Plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 16.48%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 14.31%
- • Asset Turnover: 0.93x
- • Equity Multiplier: 1.23x
- Recent ROE (16.48%) is above the historical average (4.36%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 0.00% | -349.70% | 0.56x | 0.00x | GBX-1.17 Million |
| 2003 | 0.00% | -283.33% | 0.41x | 0.00x | GBX-503.90K |
| 2004 | -55.90% | -159.45% | 0.25x | 1.39x | GBX-407.90K |
| 2005 | -32.33% | -378.62% | 0.08x | 1.08x | GBX-788.20K |
| 2006 | -4.24% | -68.01% | 0.05x | 1.25x | GBX-963.20K |
| 2007 | 4.71% | 6.28% | 0.60x | 1.26x | GBX-376.80K |
| 2008 | 4.46% | 6.19% | 0.63x | 1.15x | GBX-417.60K |
| 2009 | 8.93% | 11.05% | 0.59x | 1.38x | GBX-145.00K |
| 2010 | 8.70% | 5.94% | 1.08x | 1.35x | GBX-191.70K |
| 2011 | 10.45% | 8.68% | 0.95x | 1.27x | GBX71.80K |
| 2012 | 11.76% | 8.95% | 0.96x | 1.36x | GBX315.50K |
| 2013 | 12.70% | 9.85% | 0.99x | 1.30x | GBX543.10K |
| 2014 | 13.89% | 13.48% | 0.81x | 1.28x | GBX885.40K |
| 2015 | 14.05% | 16.02% | 0.74x | 1.18x | GBX1.08 Million |
| 2016 | 9.04% | 10.60% | 0.71x | 1.19x | GBX-273.70K |
| 2017 | 9.78% | 10.21% | 0.79x | 1.22x | GBX-67.20K |
| 2018 | 12.07% | 14.15% | 0.74x | 1.15x | GBX685.20K |
| 2019 | 10.45% | 12.79% | 0.72x | 1.14x | GBX159.60K |
| 2020 | 11.21% | 13.78% | 0.69x | 1.19x | GBX454.50K |
| 2021 | 11.62% | 14.03% | 0.70x | 1.19x | GBX652.80K |
| 2022 | 8.00% | 9.98% | 0.68x | 1.17x | GBX-828.10K |
| 2023 | 7.51% | 8.16% | 0.77x | 1.19x | GBX-836.90K |
| 2024 | 11.33% | 10.77% | 0.81x | 1.30x | GBX482.60K |
| 2025 | 16.48% | 14.31% | 0.93x | 1.23x | GBX2.66 Million |
Industry Comparison
This section compares Anpario Plc's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $983,206,052
- Average return on equity (ROE) among peers: 4.86%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Anpario Plc (ANP) | GBX40.96 Million | 0.00% | 0.23x | $1.00 Million |
| Associated British Foods PLC (ABF) | $6.51 Billion | 8.11% | 0.57x | $169.25 Million |
| Bakkavor Group PLC (BAKK) | $278.68 Million | 0.00% | 4.32x | $18.25 Million |
| Benchmark Holdings Plc (BMK) | $323.29 Million | -9.42% | 0.63x | $135.69 Million |
| Carr's Group plc (CARR) | $89.83 Million | 12.66% | 1.20x | $840.50K |
| Cranswick PLC (CWK) | $3.29 Million | 15.51% | 0.98x | $35.61 Million |
| Greencore Group (GNC) | $174.02 Million | 3.66% | 4.12x | $15.77 Million |
| Hilton Food Group Plc (HFG) | $54.26 Million | 32.86% | 3.55x | $8.04 Million |
| Premier Foods PLC (PFD) | $1.41 Billion | 9.69% | 0.58x | $21.14 Million |
| Science in Sport plc (SIS) | $4.40 Million | -29.37% | 0.41x | $938.40K |
About Anpario Plc
Anpario plc, together with its subsidiaries, manufactures and distributes animal feed additives for animal health, nutrition, and biosecurity in the Americas, Asia, Europe, the Middle East, and Africa. The company offers animal gut health products, such as phytogenic and acid based eubiotics, and omega fatty acids under the AmpLIPhy, Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; and fee… Read more